Burke & Herbert Bank & Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$409K Hold
3,235
– – 0.1% 168
2026
Q1
$451K Buy
3,235
+379
+13% +$53.1K 0.12% 149
2025
Q4
$351K Buy
2,856
+981
+52% +$119K 0.1% 165
2025
Q3
$208K Hold
1,875
– – 0.04% 230
2025
Q2
$208K Hold
1,875
– – 0.05% 233
2025
Q1
$210K Buy
+1,875
New +$193K 0.05% 221
2018
Q1
– Sell
-3,784
Closed -$271K – 136
2017
Q4
$271K Buy
3,784
+26
+0.7% +$1.97K 0.23% 116
2017
Q3
$305K Sell
3,758
-355
-9% -$27.1K 0.28% 102
2017
Q2
$291K Sell
4,113
-1,100
-21% -$73.2K 0.26% 104
2017
Q1
$354K Buy
5,213
+500
+11% +$35.2K 0.32% 91
2016
Q4
$337K Hold
4,713
– – 0.31% 90
2016
Q3
$373K Buy
4,713
+248
+6% +$20.1K 0.34% 82
2016
Q2
$372K Sell
4,465
-370
-8% -$32.8K 0.34% 73
2016
Q1
$444K Buy
4,835
+1,285
+36% +$116K 0.43% 59
2015
Q4
$359K Hold
3,550
– – 0.37% 67
2015
Q3
$349K Sell
3,550
-200
-5% -$22.2K 0.39% 66
2015
Q2
$439K Hold
3,750
– – 0.47% 60
2015
Q1
$368K Buy
3,750
+400
+12% +$40.6K 0.4% 69
2014
Q4
$316K Buy
3,350
+50
+2% +$5.17K 0.32% 75
2014
Q3
$351K Buy
3,300
+100
+3% +$9.79K 0.34% 70
2014
Q2
$265K Buy
+3,200
New +$249K 0.24% 92

Other funds holding GILD

Burke & Herbert Bank & Trust's GILD Position: Q2 2026 in Review

Burke & Herbert Bank & Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,235 shares worth $409K. The position accounts for 0.1% of the portfolio, ranked #168.

Burke & Herbert Bank & Trust first reported a position in GILD in Q2 2014 and has held it in 21 quarters since. The position peaked at $451K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Burke & Herbert Bank & Trust held 3,235 shares of Gilead Sciences worth $409K as of Q2 2026.
  • Burke & Herbert Bank & Trust left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.1% of Burke & Herbert Bank & Trust's portfolio in Q2 2026, its #168 holding.
  • Burke & Herbert Bank & Trust first reported a position in Gilead Sciences in Q2 2014 and has held it in 21 quarters since.
  • Burke & Herbert Bank & Trust's Gilead Sciences position peaked at $451K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Burke & Herbert Bank & Trust's 13F filing for Q2 2026, filed 7 Aug 2026.